+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Smart Insulin Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027

  • ID: 4851335
  • Report
  • April 2019
  • Region: Global
  • 251 pages
  • Transparency Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

Global Smart Insulin Pens Market: Overview

This report analyzes the current and future scenario of the global smart insulin pens market.

Increase in the prevalence of diabetes, as well as rise in the demand for smart insulin pens due to their additional features, are key factors that are anticipated to drive the global market scenario of the global smart insulin pens market. An increase in the prevalence of diabetes as well as a rise in the demand for smart insulin pens due to their additional features are key factors that are anticipated to drive the global market.

This report comprises an elaborate executive summary, which includes information about various segments of the global smart insulin pens market. It also provides information and data analysis of the global market with respect to the segments based on product, connectivity type, application, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview in order to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global smart insulin pens market.

Global Smart Insulin Pens Market: Key Segments

In terms of product, the global smart insulin pens market has been segmented into smart insulin pens and adaptors for conventional pens. In terms of connectivity type, the market can be has been divided into Bluetooth and USB. Based on application, the global market has been classified into type 1 and type 2 diabetes. In terms of distribution channel, the market has been segregated into hospital pharmacy, online sales, retail pharmacy, and diabetes clinics/centers. The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.

Global Smart Insulin Pens Market: Regional Outlook

In terms of region, the global smart insulin pens market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 20297 along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global smart insulin pens market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in the report include Novo Nordisk A/S, Sanofi (sanofi-aventis US LLC), Eli Lilly and Company, Companion Medical, Emperra GmbH E-Health Technologies, Diabnext, Jiangsu Delfu medical device Co.,Ltd, BERLIN-CHEMIE, DIAMESCO CO., Ltd., and Patients Pending Ltd (Bigfoot Biomedical Inc.).  

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Smart Insulin Pens Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Rise in prevalence of diabetes
4.3.1.2. Increase in awareness about diabetes
4.3.1.3. Integration of diabetes monitoring and therapeutics for better disease management
4.3.1.4. Surge in adoption of connected medical devices
4.3.2. Restraints
4.3.2.1 Availability of alternatives to insulin delivery devices
4.3.2.2. Not suitable for combination of insulin
4.3.3. Opportunities
4.4. Global Smart Insulin Pens Market Analysis and Forecast, 2019-2027

5. Market Outlook
5.1.Technological Advancement
5.2. New Product Launch & FDA Approvals
5.3. Diabetes Prevalence in Key Countries

6. Global Smart Insulin Pens Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Smart Insulin Pens Market Value Forecast, by Product, 2019-2027
6.3.1. Smart Insulin Pen
6.3.2. Adaptors for Conventional Pen
6.4. Global Smart Insulin Pens Market Attractiveness, by Product

7. Global Smart Insulin Pens Market Analysis and Forecast, by Connectivity Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Smart Insulin Pens Market Value Forecast, by Connectivity Type, 2019-2027
7.3.1. Bluetooth
7.3.2. USB
7.4. Global Smart Insulin Pens Market Attractiveness, by Connectivity Type

8. Global Smart Insulin Pens Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Global Smart Insulin Pens Market Value Forecast, by Application, 2019-2027
8.3.1. Type 1 Diabetes
8.3.2. Type 2 Diabetes
8.4. Global Smart Insulin Pens Market Attractiveness, by Application

9. Global Smart Insulin Pens Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Global Smart Insulin Pens Market Value Forecast, by Distribution Channel, 2019-2027
9.3.1. Hospital Pharmacy
9.3.2. Online Sales
9.3.3. Retail Pharmacy
9.3.4. Diabetes Clinics/Centers
9.4. Global Smart Insulin Pens Market Attractiveness, by Distribution Channel

10. Global Smart Insulin Pens Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Smart Insulin Pens Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Smart Insulin Pens Market Attractiveness, by Region

11. North America Smart Insulin Pens Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2. North America Smart Insulin Pens Market Value Forecast, by Product, 2019-2027
11.2.1. Smart Insulin Pen
11.2.2. Adaptors for Conventional Pen
11.3. North America Smart Insulin Pens Market Value Forecast, by Connectivity Type, 2019-2027
11.3.1. Bluetooth
11.3.2. USB
11.4. North America Smart Insulin Pens Market Value Forecast, by Application, 2019-2027
11.4.1. Type 1 Diabetes
11.4.2. Type 2 Diabetes
11.5. North America Smart Insulin Pens Market Value Forecast, by Distribution Channel, 2019-2027
11.5.1. Hospital Pharmacy
11.5.2. Online Sales
11.5.3. Retail Pharmacy
11.5.4. Diabetes Clinics/Centers
11.6. North America Smart Insulin Pens Market Value Forecast, by Country, 2019-2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Smart Insulin Pens Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Connectivity Type
11.7.3. By Application
11.7.4. By Distribution Channel
11.7.5. By Country

12. Europe Smart Insulin Pens Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Europe Smart Insulin Pens Market Value Forecast, by Product, 2019-2027
12.2.1. Smart Insulin Pen
12.2.2. Adaptors for Conventional Pen
12.3. Europe Smart Insulin Pens Market Value Forecast, by Connectivity Type, 2019-2027
12.3.1. Bluetooth
12.3.2. USB
12.4. Europe Smart Insulin Pens Market Value Forecast, by Application, 2019-2027
12.4.1. Type 1 Diabetes
12.4.2. Type 2 Diabetes
12.5. Europe Smart Insulin Pens Market Value Forecast, by Distribution Channel, 2019-2027
12.5.1. Hospital Pharmacy
12.5.2. Online Sales
12.5.3. Retail Pharmacy
12.5.4. Diabetes Clinics/Centers
12.6. Europe Smart Insulin Pens Market Value Forecast, by Country/Sub-region, 2019-2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Smart Insulin Pens Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Connectivity Type
12.7.3. By Application
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region

13. Asia Pacific Smart Insulin Pens Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2. Asia Pacific Smart Insulin Pens Market Value Forecast, by Product, 2019-2027
13.2.1. Smart Insulin Pen
13.2.2. Adaptors for Conventional Pen
13.3. Asia Pacific Smart Insulin Pens Market Value Forecast, by Connectivity Type, 2019-2027
13.3.1. Bluetooth
13.3.2. USB
13.4. Asia Pacific Smart Insulin Pens Market Value Forecast, by Application, 2019-2027
13.4.1. Type 1 Diabetes
13.4.2. Type 2 Diabetes
13.5. Asia Pacific Smart Insulin Pens Market Value Forecast, by Distribution Channel, 2019-2027
13.5.1. Hospital Pharmacy
13.5.2. Online Sales
13.5.3. Retail Pharmacy
13.5.4. Diabetes Clinics/Centers
13.6. Asia Pacific Smart Insulin Pens Market Value Forecast, by Country/Sub-region, 2019-2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Smart Insulin Pens Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Connectivity Type
13.7.3. By Application
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region

14. Latin America Smart Insulin Pens Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2. Latin America Smart Insulin Pens Market Value Forecast, by Product, 2019-2027
14.2.1. Smart Insulin Pen
14.2.2. Adaptors for Conventional Pen
14.3. Latin America Smart Insulin Pens Market Value Forecast, by Connectivity Type, 2019-2027
14.3.1. Bluetooth
14.3.2. USB
14.4. Latin America Smart Insulin Pens Market Value Forecast, by Application, 2019-2027
14.4.1. Type 1 Diabetes
14.4.2. Type 2 Diabetes
14.5. Latin America Smart Insulin Pens Market Value Forecast, by Distribution Channel, 2019-2027
14.5.1. Hospital Pharmacy
14.5.2. Online Sales
14.5.3. Retail Pharmacy
14.5.4. Diabetes Clinics/Centers
14.6. Latin America Smart Insulin Pens Market Value Forecast, by Country/Sub-region, 2019-2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Smart Insulin Pens Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Connectivity Type
14.7.3. By Application
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region

15. Middle East & Africa Smart Insulin Pens Market Analysis and Forecast
15.1.Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Smart Insulin Pens Market Value Forecast, by Product, 2019-2027
15.2.1. Smart Insulin Pen
15.2.2. Adaptors for Conventional Pen
15.3. Middle East & Africa Smart Insulin Pens Market Value Forecast, by Connectivity Type, 2019-2027
15.3.1. Bluetooth
15.3.2. USB
15.4. Middle East & Africa Smart Insulin Pens Market Value Forecast, by Application, 2019-2027
15.4.1. Type 1 Diabetes
15.4.2. Type 2 Diabetes
15.5. Middle East & Africa Smart Insulin Pens Market Value Forecast, by Distribution Channel, 2019-2027
15.5.1. Hospital Pharmacy
15.5.2. Online Sales
15.5.3. Retail Pharmacy
15.5.4. Diabetes Clinics/Centers
15.6. Middle East & Africa Smart Insulin Pens Market Value Forecast, by Country/Sub-region, 2019-2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Smart Insulin Pens Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Connectivity Type
15.7.3. By Application
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region

16. Competition Landscape
16.1.Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Global Smart Insulin Pens Market Share Analysis, by Company (2018)
16.3. Company Profiles
16.3.1. Novo Nordisk A/S
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 SWOT Analysis
16.3.1.4 Financial Overview
16.3.1.5 Strategic Overview
16.3.2. Sanofi (sanofi-aventis US LLC)
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 SWOT Analysis
16.3.2.4 Financial Overview
16.3.2.5 Strategic Overview
16.3.3. Eli Lilly and Company
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 SWOT Analysis
16.3.3.4 Financial Overview
16.3.3.5 Strategic Overview
16.3.4. Companion Medical
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 SWOT Analysis
16.3.4.4 Strategic Overview
16.3.5. Emperra GmbH E-Health Technologies
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 SWOT Analysis
16.3.5.4 Strategic Overview
16.3.6. Diabnext
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 SWOT Analysis
16.3.7. Jiangsu Delfu medical device Co.,Ltd
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 SWOT Analysis
16.3.8. BERLIN-CHEMIE
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 SWOT Analysis
16.3.8.4 Strategic Overview
16.3.9. DIAMESCO CO., Ltd.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 SWOT Analysis
16.3.10. Patients Pending Ltd (Bigfoot Biomedical Inc.)
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 SWOT Analysis
16.3.10.4 Strategic Overview
Note: Product cover images may vary from those shown
Adroll
adroll